How THC Reduces Eye Pressure
CB1 receptors are expressed in ocular tissues including the ciliary body, which produces aqueous humour. THC activation of these receptors reduces aqueous humour production and increases trabecular outflow, decreasing IOP. This mechanism was identified in the 1970s through research conducted under FDA-approved Investigational New Drug (IND) protocols. The challenge is that THC's IOP-lowering effect lasts only 3-4 hours, requiring dosing 6-8 times daily for continuous pressure control. Understanding THC's pharmacology helps patients and clinicians optimise dosing. Pain relief effects are also relevant as glaucoma can cause acute ocular pain.
Clinical Evidence & Research
Multiple studies from the 1970s-1990s established that smoked cannabis reduces IOP by 25-30% for 3-4 hours. However, a 2003 American Academy of Ophthalmology review noted that the dosing frequency required for 24-hour IOP control would result in constant intoxication, limiting practical utility. More recent research has focused on cannabinoid eye drops, which could deliver targeted IOP reduction without systemic effects. CBD alone paradoxically increases IOP transiently — an important finding for glaucoma patients using CBD-dominant products without THC. Israel and the Netherlands permit medical cannabis for glaucoma.
Access & Patient Requirements
Glaucoma is a qualifying condition in 30+ US medical cannabis states, making it one of the most widely accepted eye conditions. An ophthalmologist diagnosis and documented IOP measurements are typically required. California has included glaucoma since its programme inception. Colorado and New York both accept glaucoma. Most ophthalmologists are cautious about recommending cannabis as primary glaucoma therapy due to the dosing frequency limitation.
Recommended Cannabis Approaches for Glaucoma
For most glaucoma patients, cannabis is adjunctive therapy rather than primary IOP management. THC (via vaporisation or sublingual) can provide acute IOP relief during pressure spikes or complement prescription eye drops. Night-time dosing may be most practical as conventional IOP medications often have their lowest efficacy during sleep. Avoid CBD-only products for glaucoma, as CBD can transiently increase IOP. Monitor IOP with your ophthalmologist regularly if using cannabis as part of your glaucoma management. THC dosing guidelines should be discussed with your eye care specialist.